Prophylactic effect of highly selective COX-2 inhibition in acute monosodium urate crystal induced inflammation in the rat subcutaneous air pouch

Journal of Rheumatology

Volumn 32, Issue 9, 2005, Pages 1762-1764

  Nalbant, Selim ^a   Chen, Lan X ^a,b   Sieck, Marie S ^a,b   Clayburne, Gilda ^a,b   Schumacher, H Ralph ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Air pouch; Coxib; Gout; Inflammation

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ROFECOXIB; TUMOR NECROSIS FACTOR ALPHA; URATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYSTAL; DRUG EFFECT; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; GOUT; INFLAMMATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RAT; RAT STRAIN;

ANIMALS; ARTHRITIS, GOUTY; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; LACTONES; MALE; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SULFONES; URIC ACID;

EID: 24944536063     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Turner RE, Frank MJ, Van Ausdal D, Bollet AJ. Some aspects of the epidemiology of gout. Sex and race incidence. Arch Intern Med 1960;106:400-6.
2. Li-Yu J, Clayburne G, Sieck M, et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001;28:577-80.
3. Schumacher HR, Boice JA, Daikh DI, et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ 2002;324:1488-93.
4. Altman RD, Honig S, Levin JM, Lightfoot RW. Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study. J Rheumatol 1988;15:1422-6.
5. Lomen PL, Turner LF, Lamborn KR, Winblad MA, Sack RL, Brinn EL. Flurbiprofen in the treatment of acute gout: a comparison with indomethacin. Am J Med 1986;80:134-9.
6. Kohn NN, Hughes RE, McCarty DJ Jr, Faires JS. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals. Ann Intern Med 1962;56:738-45.
7. Ferrari AJL, van Linthoudt D, Morrone L, Branigan P, Schumacher HR, Baker DG. Nonsteroidal anti-inflammatory drugs and prostaglandins: their interactions and effects on the particulate-induced inflammatory process implicated in joint implant-loosening and on monosodium urate crystal-induced inflammation. Am J Ther 1996;3:189-94.
8. Edwards JCW, Sedgwick AD, Willooghbg DA. The formation of a structure with the features of synovial lining by subcutaneous injection air: an in vivo tissue culture system. J Pathol 1981;134:147-56.
9. Nagase M, Baker DG, Schumacher HR. Prolonged inflammatory reactions induced by artificial ceramics in the rat air pouch model. J Rheumatol 1988;15:1334-8.
10. Leukocyte count. In: Schumacher HR, Reginato AJ, editors. Atlas of synovial fluid analysis and crystal identification. Philadelphia: Lea and Febiger; 1991:27-31.
11. Pouliot M, James MJ, McColl SR, Naccache PH, Cleland LG. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998;91:1769-76.
12. Martin AR, Villegas I, La Casa C, Alarcon de la Lastra C. The cyclo-oxygenase-2 inhibitor, rofecoxib, attenuates mucosal damage due to colitis induced by trinitrobenzene sulphonic acid in rats. Eur J Pharmacol 2003;481:281-91.
13. Pinheiro RM, Calixto JB. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib, in rat acute models of inflammation. Inflamm Res 2002;51:603-10.